Affinity Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,923
| Closed | -$337K | – | 157 |
|
|
2025
Q1 | $337K | Buy |
21,923
+3,356
| +18% | +$51.6K | 0.27% | 102 |
|
|
2024
Q4 | $409K | Buy |
18,567
+2,376
| +15% | +$52.4K | 0.34% | 92 |
|
|
2024
Q3 | $292K | Hold |
16,191
| – | – | 0.2% | 114 |
|
|
2024
Q2 | $263K | Sell |
16,191
-8,626
| -35% | -$140K | 0.2% | 112 |
|
|
2024
Q1 | $350K | Hold |
24,817
| – | – | 0.26% | 101 |
|
|
2023
Q4 | $259K | Buy |
24,817
+636
| +3% | +$6.64K | 0.18% | 158 |
|
|
2023
Q3 | $247K | Sell |
24,181
-7,336
| -23% | -$74.8K | 0.16% | 169 |
|
|
2023
Q2 | $237K | Buy |
+31,517
| New | +$237K | 0.14% | 179 |
|